Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Nature Microbiology(2)
Nature Communications(1)
Scientific Reports(1)
The Lancet Infectious Diseases(1)
Área temáticas
Enfermedades(4)
Medicina forense; incidencia de enfermedades(4)
Medicina y salud(3)
Microorganismos, hongos y algas(2)
Biología(1)
Origen
scopus(5)
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
ArticleAbstract: The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and DPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams A., Adams H., Afifi S., Aggarwal D., Ahmad S.S.Y., Aigrain L., Alcolea-Medina A., Alikhan N.F., Allara E., Amato R., Angyal A., Annett T., Antonelli M., Aplin S., Ariani C.V., Asad H., Ash A., Ashfield P., Ashford F., Atkinson L., Attwood S.W., Auckland C., Aydin A., Baker D.J., Baker P., Balcazar C.E., Ball J., Barrett J.C., Barrow M., Barton E., Bashton M., Bassett A.R., Batra R., Baxter C., Bayzid N., Beaver C., Beckett A.H., Beckwith S.M., Bedford L., Beer R., Beggs A., Bellis K.L., Bernardo M. Gutierrez, Berry L., Bertolusso B., Best A., Betteridge E., Bibby D., Bicknell K., Binns D., Birchley A., Bird P.W., Bishop C., Blacow R., Blakey V., Blane B., Bolt F., Bonfield J., Bonner S., Bonsall D., Boswell T., Bosworth A., Bourgeois Y., Boyd O., Bradley D.T., Breen C., Bresner C., Breuer J., Bridgett S., Bronner I.F., Brooks E., Broos A., Brown J.R., Bucca G., Buchan S.L., Buck D., Bull M., Burns P.J., Burton-Fanning S., Byaruhanga T., Byott M., Campbell S., Canas L.S., Capdevila J., Carabelli A.M., Cargill J.S., Carlile M., Carvalho S.F., Chen L., Deng J., Fox B., Graham M.S., Kerfoot E., Kläser K., May A., Molteni E., Murray B., Österdahl M.F., Wolf J.Fuentes:scopusGenomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
ArticleAbstract: Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effePalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aggarwal D., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Chen C., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Debebe J., Edgeworth J., Ellaby N., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Groves N., Guest M., Gulliver H., Harrison A., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Howson-Wells H.C., Hughes G.J., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Le Viet T., Lister M.M., Logan S., Loose M.W., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Myers R., Nebbia G., Page A.J., Patel A., Platt S., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Savva G.M., Schaefer U., Sheriff N., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Tumelty N.M., Turner C., Underwood A.P., Volz E.M., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A.Fuentes:scopusHospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
ArticleAbstract: Background: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. IPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams H., Afifi S., Aliabadi S., Ash A., Batra R., Beckett A.H., Beer R., Bernardo M. Gutierrez, Berry L., Betancor G., Bird P.W., Blakey V., Bonsall D., Boswell T., Bresner C., Campbell S., Carlile M., Charalampous T., Charlett A., Clark G., Cogger B.J., Coll F., Connor T.R., Cortes N., Curran T., Dabrera G., De Angelis D., Debebe J., Edgeworth J., Fairley D.J., Fallon K., Fleming V.M., Fraser C., Fuller W., Gallagher E., Golubchik T., Guest M., Gulliver H., Harris R.J., Hassan-Ibrahim M.O., Helmer T., Holmes C., Holmes N., Hope R., Howson-Wells H.C., John M., Jones C., Joseph A., Khakh M., Kidd S., Kitchen C., Koshy C., Lister M.M., Loose M.W., Lopez-Bernal J., Lynch J., Maksimovic J., Malone C.S., Marchbank A., McCluggage K., McKenna J.P., Menegazzo M., Merrick I., Moore C., Moore N., Morgan S., Mori M., Munn R., Nebbia G., Nyberg T., Patel A., Presanis A.M., Price A., Raviprakash V., Reynolds N., Robson S.C., Sang F., Seaman S.R., Sheriff N., Signell A.W., Sinnathamby M.A., Smith W., Snell L.B., Southgate J., Spellman K., Tang J., Taylor B.E.W., Thelwall S., Twohig K.A., Underwood A.P., Wantoch M., Warne B., Williams L.A., Willingham I., Wise E.L., Workman T., Wright V., Yeats C.A., Zaidi A.Fuentes:scopusSARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
ArticleAbstract: Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response toPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T.I., Deeks A.S., Dunachie S.J., Duncan C.J.A., Edgeworth J., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K.E., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusPublisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (Nature Microbiology, (2022), 7, 8, (1161-1179), 10.1038/s41564-022-01143-7)
OtherAbstract: In the version of this article initially published, the author affiliation information was incompletPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T., Deeks A.S., Dunachie S., Dunachie S.J., Duncan C.J.A., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R.N., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopus